Highlights in nanocarriers for the treatment against cervical cancer

In an in ideal scenario of cancer treatment, the early phase of this transformation journey is detected noninvasively in routine checks through imaging and analysis, targeted drugs are delivered at the specific sites selectively with minimal collateral damage by carriers that overcome biological barriers, and the transforming population of cells are eliminated (Ferrari, 2005). Such treatment can be repeated based on individualized needs. This envisioned treatment scenario is still far in the future, but several applications of nanotechnology in cancer treatment are showing signs of promise of transforming this vision into reality.